McElroy N D, Zimmerman B G
Department of Pharmacology, University of Minnesota Medical School, Minneapolis 55455.
Hypertension. 1989 Jun;13(6 Pt 2):851-8. doi: 10.1161/01.hyp.13.6.851.
alpha-Adrenergic receptor subtypes were investigated using [3H]prazosin, an alpha 1 selective antagonist, and the alpha 2 selective antagonist [3H]rauwolscine in a smooth muscle plasma membrane enriched microsomal fraction prepared from rabbit intrarenal arterial vasculature. Both radioligands displayed single components on Scatchard analysis. The specific binding of [3H]prazosin was of high affinity (0.54 +/- 0.04 nM) with a maximum binding capacity (Bmax) of 212 +/- 15 fmol/mg protein. The maximum number of [3H]rauwolscine binding sites was 64 +/- 4 fmol/mg of protein with a dissociation constant (Kd) of 5.60 +2- 0.27 nM. Binding of both radioligands was rapid, saturable, and specific. alpha 1- and alpha 2-adrenergic receptors in the intrarenal arterial membrane preparation were also characterized at 2-, 4-6-, and 10-12-week intervals during the course of development and maintenance of chronic two-kidney, one clip (2K1C) Goldblatt hypertension and in age-matched sham-operated normotensive control rabbits. The alpha 1-adrenergic receptor affinity for [3H]prazosin binding in hypertensive rabbits was significantly increased in the stenotic, but not contralateral, kidney at 2 weeks; however, at 6 weeks the receptor affinity of both kidneys was significantly increased compared with those of the normotensive control group. No difference in alpha 1-adrenergic receptor affinity was seen at 12 weeks, and there were no changes in Bmax at any of the weekly intervals. Neither the Kd, nor Bmax, for [3H]rauwolscine in either kidney showed a significant difference between hypertensive rabbits and normotensive control rabbits. These studies demonstrate the existence in the rabbit intrarenal arterial vasculature of binding sites with alpha 1- and alpha 2-adrenergic receptor specificity.(ABSTRACT TRUNCATED AT 250 WORDS)
使用α1选择性拮抗剂[3H]哌唑嗪和α2选择性拮抗剂[3H]育亨宾,在从兔肾内动脉血管系统制备的富含微粒体部分的平滑肌质膜中研究α-肾上腺素能受体亚型。两种放射性配体在Scatchard分析中均显示单一成分。[3H]哌唑嗪的特异性结合具有高亲和力(0.54±0.04 nM),最大结合容量(Bmax)为212±15 fmol/mg蛋白质。[3H]育亨宾结合位点的最大数量为64±4 fmol/mg蛋白质,解离常数(Kd)为5.60±0.27 nM。两种放射性配体的结合都是快速、饱和且特异性的。在慢性二肾一夹(2K1C)Goldblatt高血压的发生和维持过程中,以及在年龄匹配的假手术正常血压对照兔中,还在2周、4 - 6周和10 - 12周的间隔时间对肾内动脉膜制剂中的α1和α2肾上腺素能受体进行了表征。在2周时,高血压兔狭窄肾而非对侧肾中,[3H]哌唑嗪结合的α1肾上腺素能受体亲和力显著增加;然而,在6周时,与正常血压对照组相比,两个肾的受体亲和力均显著增加。在12周时未观察到α1肾上腺素能受体亲和力的差异,并且在任何每周间隔时间Bmax均无变化。高血压兔和正常血压对照兔的肾脏中,[3H]育亨宾的Kd和Bmax均未显示出显著差异。这些研究证明兔肾内动脉血管系统中存在具有α1和α2肾上腺素能受体特异性的结合位点。(摘要截短于250字)